What Is Compounded Semaglutide?

Compounded semaglutide is a custom-made prescription medication prepared by a compounding pharmacy for one patient. It contains semaglutide, a GLP-1 receptor agonist used in FDA-approved drugs like Wegovy, Ozempic, and Rybelsus, but compounded semaglutide itself is not FDA-approved and should only be used with licensed medical supervision.

What is compounded semaglutide?

Compounded semaglutide is semaglutide prepared by a compounding pharmacy for a specific patient when a licensed clinician writes a prescription. Under federal law, traditional 503A compounding is patient-specific and is different from mass manufacturing an FDA-approved drug 1.

Plain English: a compounded medication is made for an individual prescription. It may come in a formulation, concentration, or package that is not the same as a brand-name product. It is not reviewed by FDA before dispensing the way an FDA-approved medication is reviewed 2.

A 503A compounding pharmacy is generally a state-licensed pharmacy that compounds medication after receiving a valid prescription for an identified patient. That licensed path is very different from buying “research” products or no-prescription injections online, where the source, sterility, identity, and strength may be unclear 1.

Why compounded medications are not FDA-approved generics

A generic drug must show it is the same active ingredient, dosage form, strength, route, and performance as the FDA-approved reference product. A compounded medication is not approved through that generic pathway, so it should not be called a generic version of Ozempic, Wegovy, Rybelsus, or any other brand-name semaglutide product 3.

How is compounded semaglutide different from Wegovy, Ozempic, and Rybelsus?

Semaglutide is the active ingredient in several FDA-approved brand-name drugs, but each product has its own approved use, dosage form, labeling, and data package. Compounded semaglutide via a 503A pharmacy is a prescription compounded medication, not an FDA-approved brand or generic.

The difference matters because evidence is product-specific. Clinical trial results for Wegovy, Ozempic, or Rybelsus tell us about semaglutide as studied in those products; they do not mean every compounded formulation has the same FDA-reviewed safety, effectiveness, or quality data.

How does semaglutide work in the body?

Semaglutide is a GLP-1 receptor agonist, also called a glucagon-like peptide-1 receptor agonist. It acts like a hormone signal involved in appetite regulation, satiety signaling, blood glucose control, insulin secretion, glucagon suppression, and gastric emptying 4.

In simple terms, semaglutide can help the brain and gut send stronger “I’m full” signals. It can also slow how fast the stomach empties, which may reduce hunger but can also cause nausea, vomiting, bloating, constipation, diarrhea, or stomach pain 4.

In the STEP 1 trial, adults with obesity or overweight without diabetes received once-weekly semaglutide 2.4 mg plus lifestyle support; the semaglutide group had greater average weight loss than placebo over 68 weeks. Gastrointestinal side effects were common, and more people stopped treatment because of gastrointestinal events with semaglutide than placebo; individual results vary 7.

In type 2 diabetes trials, semaglutide lowered A1c and body weight compared with several comparators, but labeling also warns about hypoglycemia risk when used with insulin or sulfonylureas, diabetic retinopathy complications in some patients, gallbladder disease, kidney injury, and pancreatitis warnings 5.

What is compounded semaglutide made of?

Compounded semaglutide formulations can vary by prescription and pharmacy. They may contain semaglutide, sterile water or another vehicle for injection, and sometimes added ingredients, but the exact formulation should be confirmed by the prescriber and dispensing pharmacy.

FDA has warned that some compounders may use semaglutide salt forms, including semaglutide sodium and semaglutide acetate. FDA has stated it is not aware of a lawful basis for using those salt forms in compounding and that they are different active ingredients from the semaglutide base used in FDA-approved products 2.

Some compounded prescriptions may include added ingredients such as vitamin B12. That does not make the medication automatically better or safer. Patients should ask what exact form of semaglutide is being used, whether any added ingredient is medically needed, and how the dose is measured.

Is compounded semaglutide safe?

Safety depends on the patient, prescription, and pharmacy. Compounded semaglutide can carry semaglutide-class risks plus compounding-specific risks, such as formulation variation, sterility problems, and dosing errors.

FDA-approved semaglutide labels include a boxed warning about thyroid C-cell tumors seen in rodents and state that semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 4.

Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, bloating, belching, low blood sugar in some people with type 2 diabetes, and reflux symptoms 4. Serious warnings include pancreatitis, gallbladder disease, acute kidney injury, hypersensitivity reactions, diabetic retinopathy complications, increased heart rate, and suicidal behavior or ideation monitoring in weight-management labeling 4.

Dosing errors are a special concern with compounded semaglutide because some prescriptions use vials and syringes. FDA has received adverse event reports linked to patients measuring the wrong amount, confusing milligrams, milliliters, and units, or taking more than prescribed 8.

• Seek urgent care for severe or lasting abdominal pain, especially with vomiting, because pancreatitis is a labeled warning for semaglutide products 4.
• Call a clinician promptly for signs of dehydration, low urine output, severe vomiting, or diarrhea, because kidney injury has been reported with GLP-1 medicines, often in the setting of dehydration 4.
• People using insulin or sulfonylureas need careful clinician monitoring because hypoglycemia risk can increase when semaglutide is combined with those medicines 5.
• Pregnancy planning, pregnancy, and breastfeeding require clinician review. Wegovy labeling advises stopping semaglutide at least 2 months before a planned pregnancy because of its long washout time 4.

Will compounded semaglutide help with weight loss?

Semaglutide has strong weight-management data in FDA-approved trials, but compounded semaglutide does not have the same product-specific FDA-reviewed outcomes data. Results with any semaglutide treatment vary by eligibility, medical history, dose plan, side effects, adherence, nutrition, activity, sleep, and follow-up.

In STEP 1, the FDA-approved semaglutide 2.4 mg injection studied for chronic weight management produced larger average weight loss than placebo over 68 weeks, with lifestyle counseling in both groups. The same study also found more gastrointestinal side effects and treatment stops from gastrointestinal events in the semaglutide group; individual results vary 7.

This is why we avoid promising outcomes for a compounded formulation. A clinician evaluation matters because the right question is not only “Can semaglutide reduce appetite?” It is also “Is this safe for this person, with this history, this medication list, and this follow-up plan?”

Why can compounded semaglutide cost less than brand-name options?

Cost differences often come from insurance, cash-pay pricing, and different regulatory pathways. Brand-name drugs carry FDA approval costs, manufacturer pricing, and insurance rules. Compounded medications follow a different pathway and are often paid for in cash.

Lower cost should still be weighed against quality, legality, and clinical oversight. A valid prescription, a licensed clinician, clear dosing instructions, adverse event support, and a state-licensed 503A compounding pharmacy are more important than chasing the lowest price.

Who may be eligible for semaglutide treatment?

Eligibility is a medical decision. FDA-approved weight-management labeling for Wegovy includes adults with obesity or adults with overweight plus at least one weight-related condition, and pediatric patients age 12 and older with obesity, alongside a reduced-calorie diet and increased physical activity 4.

A clinician should review BMI, weight-related conditions, blood glucose and A1c history, diabetes medications, prior pancreatitis, gallbladder disease, kidney issues, severe gastrointestinal disease, diabetic retinopathy, thyroid cancer history, pregnancy plans, pregnancy, breastfeeding, allergies, and current medications 4.

People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use semaglutide products under FDA labeling. People with pancreatitis history, gallbladder disease, kidney disease, diabetic retinopathy, or insulin or sulfonylurea use may need extra caution and monitoring 4.

How does compounded semaglutide work at Chia?

At Chia, compounded semaglutide is offered as an injection, with plans currently starting at $249/month. Patients begin with a short online health questionnaire, then a licensed US provider reviews their history and prescribes only when clinically appropriate.

Our semaglutide injection path includes provider-guided dosing and dose adjustments over time. Microdosing plans are available when clinically appropriate. Patients can message their care team through the patient portal between visits.

When prescribed, medication is compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Some patients also ask about tirzepatide tablets or injections, or protocols like Weight + Energy and Weight + Muscle, which combine a GLP-1 choice with other treatments listed in Chia’s current catalog.

What should you ask before taking compounded semaglutide?

Ask practical safety questions before starting. The goal is not to self-prescribe. The goal is to make sure a real clinician is reviewing your health and a legitimate pharmacy is filling the prescription.

1. 1Is the pharmacy state-licensed, and is it operating as a 503A compounding pharmacy for patient-specific prescriptions?
2. 2Was the prescription written by a licensed clinician after a real medical review?
3. 3What exact form is used: semaglutide base, semaglutide sodium, semaglutide acetate, or something else?
4. 4How are the instructions written: milligrams, milliliters, syringe units, or another measurement?
5. 5How will side effects like nausea, vomiting, diarrhea, constipation, reflux, or abdominal pain be handled?
6. 6What follow-up is included, and how can adverse events be reported?
7. 7Do my conditions or medicines raise concerns, including diabetes medications, pregnancy plans, pancreatitis history, gallbladder disease, kidney issues, or thyroid cancer history?

If a source does not require a prescription, does not name the pharmacy, or sells semaglutide as a research chemical, that is a different risk category. FDA and professional pharmacy standards center on valid prescriptions, appropriate compounding, and patient-specific clinical oversight 1.

Frequently asked questions about compounded semaglutide

Keep reading

Weight Loss

Peptide Injections for Weight Loss: What Actually Works

GLP-1 Medications

How to Buy Ozempic for Weight Loss: Access, Cost, and Alternatives

GLP-1 medications

Oral Semaglutide Dose for Weight Loss: A Patient Guide